ABN AMRO Morgans valueing it at 22 cents.....now that is scary. They did a wonderful job on production estimates for LAF.....PMSL
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%